178 filings
CT ORDER
Arcturus Therapeutics Holdings, Inc.
10 Jan 24
Confidential treatment order
5:08pm
UPLOAD
Arcturus Therapeutics Holdings, Inc.
4 Sep 19
Letter from SEC
12:00am
CORRESP
Arcturus Therapeutics Holdings, Inc.
16 Aug 19
Correspondence with SEC
12:00am
UPLOAD
Arcturus Therapeutics Holdings, Inc.
6 Aug 19
Letter from SEC
12:00am
8-K
Arcturus Therapeutics Holdings, Inc.
1 Aug 19
Entry into a Material Definitive Agreement
12:08pm
S-8
s55e7qa6g
21 Jun 19
Registration of securities for employees
5:04pm
8-K
kdjogkhrl4y94 wh
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
t3r61kihj0utdf1cw63
20 May 19
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
heeoahie
13 May 19
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
5:13pm
10-Q
atwwr8rqrqeejbe
13 May 19
Quarterly report
12:00am
EFFECT
t58b9018
15 Apr 19
Notice of effectiveness
12:16am
424B3
v2x p7zgw
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
n98l96
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
CORRESP
6lgoc5afweai g0a7qqq
11 Apr 19
Correspondence with SEC
12:00am
CT ORDER
plyn9md chnp9iy8qaab
11 Apr 19
Confidential treatment order
12:00am
10-K/A
9g2wro3 9kuc
10 Apr 19
Annual report (amended)
2:52pm
8-K
8ttrcdej hwjk
19 Mar 19
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results
12:00am
10-K
35lof 1gn2azy0cr5i
18 Mar 19
Annual report
12:00am
S-4
eu6np8obj5gu4aji
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
8-K
g7tzatspkfs1uft
27 Feb 19
Regulation FD Disclosure
8:00am